Respiratory Syncytial Virus (RSV) Knowledge and Perceived RSV Risk Groups Amongst GP/PCPs and Specialists in APAC: A Cross-Sectional Knowledge Attitude and Practices Survey (RESVIKAP)
Author(s)
Lawrence Vandervoort, Master’s in Public Health (MPH)1, Amanda Woo, PhD1, Neeyor Bose, PhD1, Maria Choufany, PhD2, Aruni K. Seneviratna, Master of Public Health (MPH)3, Yu-Fan Ho, MPH3.
1Oracle Life Sciences, Singapore, Singapore, 2Oracle Life Sciences, Paris, France, 3Real World Evidence & Health Outcomes, GlaxoSmithKline, Singapore, Singapore.
1Oracle Life Sciences, Singapore, Singapore, 2Oracle Life Sciences, Paris, France, 3Real World Evidence & Health Outcomes, GlaxoSmithKline, Singapore, Singapore.
OBJECTIVES: Respiratory Syncytial Virus (RSV) is a leading cause of global respiratory morbidity among the adult population ≥50 years. Healthcare practitioners (HCPs) are trusted sources of vaccine recommendations. This study aims to assess HCP’s knowledge of RSV to identify educational gaps and enhance older adult patient care.
METHODS: This descriptive, cross-sectional, study was conducted using online-based survey to assess the knowledge, attitudes and practices towards respiratory infections including RSV among HCPs in Australia, Hong Kong, Japan, New Zealand, South Korea, Singapore, and Taiwan. Respondents included 700 General Practitioners (GP) or Primary Care Physicians (PCP) and 825 specialists (140 cardiologists, endocrinologists, gastroenterologists, nephrologists and pulmonologists. 70 geriatricians and 55 infectious disease specialists).Questionnaire items pertained to knowledge of RSV disease symptoms, risk factors and complications, perceptions towards RSV infection, and knowledge topics of importance amongst older adult patients.
RESULTS: At least 80% of GPs and specialists were aware of RSV seasonality and increase in the risk of infection with age. 37% of GP/PCPs agreed that RSV infection caused fewer patients to be admitted to the hospital than influenza while 24% disagreed. When asked whether RSV infection cause fewer patients to be admitted to the hospital than influenza, 24% of GP/PCPs disagreed, and 37% agreed. 39-49% of specialists agreed, while 15%-23% disagreed.When asked which adult groups had a higher risk of getting RSV infections, 16% of GPs/PCPs and 9-16% of specialists (except 27% of pulmonologists) recognised adults aged 50-64 years were at risk. In contrast 83% of GPs/PCPs and 76%-87% of specialists recognised that adults aged ≥65 years were at risk of RSV.
CONCLUSIONS: While HCPs recognise the importance of RSV seasonality and the risks it poses among older adults, those aged 50-64 were not commonly seen as at risk of RSV infection. These perceptions may limit the utilisation of RSV vaccination where available.
METHODS: This descriptive, cross-sectional, study was conducted using online-based survey to assess the knowledge, attitudes and practices towards respiratory infections including RSV among HCPs in Australia, Hong Kong, Japan, New Zealand, South Korea, Singapore, and Taiwan. Respondents included 700 General Practitioners (GP) or Primary Care Physicians (PCP) and 825 specialists (140 cardiologists, endocrinologists, gastroenterologists, nephrologists and pulmonologists. 70 geriatricians and 55 infectious disease specialists).Questionnaire items pertained to knowledge of RSV disease symptoms, risk factors and complications, perceptions towards RSV infection, and knowledge topics of importance amongst older adult patients.
RESULTS: At least 80% of GPs and specialists were aware of RSV seasonality and increase in the risk of infection with age. 37% of GP/PCPs agreed that RSV infection caused fewer patients to be admitted to the hospital than influenza while 24% disagreed. When asked whether RSV infection cause fewer patients to be admitted to the hospital than influenza, 24% of GP/PCPs disagreed, and 37% agreed. 39-49% of specialists agreed, while 15%-23% disagreed.When asked which adult groups had a higher risk of getting RSV infections, 16% of GPs/PCPs and 9-16% of specialists (except 27% of pulmonologists) recognised adults aged 50-64 years were at risk. In contrast 83% of GPs/PCPs and 76%-87% of specialists recognised that adults aged ≥65 years were at risk of RSV.
CONCLUSIONS: While HCPs recognise the importance of RSV seasonality and the risks it poses among older adults, those aged 50-64 were not commonly seen as at risk of RSV infection. These perceptions may limit the utilisation of RSV vaccination where available.
Conference/Value in Health Info
2025-11, ISPOR Europe 2025, Glasgow, Scotland
Value in Health, Volume 28, Issue S2
Code
EPH208
Topic
Epidemiology & Public Health, Health Service Delivery & Process of Care
Topic Subcategory
Public Health
Disease
Respiratory-Related Disorders (Allergy, Asthma, Smoking, Other Respiratory), Vaccines